Veloxis Pharmaceuticals Receives Notice of Allowance from US Patent Office for ... Wall Street Journal The subject patent covers a method of administering Envarsus(R), Veloxis' once-daily formulation of tacrolimus employing the company's proprietary MeltDose(R) technology, once-daily in the evening (as opposed to morning dosing) to a kidney transplant ... |
